Immediate Impact
20 standout
Citing Papers
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
2024 Standout
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
2024 Standout
Works of Alberto Mello e Silva being referenced
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
2021
Pharmaceutical strategies for reducing LDL-C and risk of cardiovascular disease
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alberto Mello e Silva | 98 | 55 | 38 | 58 | 15 | 189 | |
| Ryoko Umebayashi | 54 | 31 | 20 | 43 | 23 | 224 | |
| H Asita de Silva | 120 | 35 | 45 | 123 | 12 | 247 | |
| Georgia Anastasiou | 54 | 21 | 40 | 56 | 24 | 192 | |
| José Seijas‐Amigo | 105 | 35 | 41 | 94 | 21 | 205 | |
| Julia Caroline Michaeli | 72 | 67 | 15 | 19 | 23 | 218 | |
| Aparna Sajja | 112 | 26 | 63 | 75 | 23 | 298 | |
| Muhammad Qamar Masood | 77 | 20 | 64 | 22 | 27 | 172 | |
| Subhash C. Manchanda | 108 | 12 | 57 | 76 | 10 | 192 | |
| István Reiber | 124 | 44 | 73 | 48 | 19 | 165 | |
| Michel Scemama | 79 | 24 | 32 | 48 | 20 | 149 |
All Works
Login with ORCID to disown or claim papers
Loading papers...